PTCL

Clinical trials for PTCL explained in plain language.

Never miss a new study

Get alerted when new PTCL trials appear

Sign up with your email to follow new studies for PTCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 4 Not yet finished but already full! 1 Completed 1

New drug cocktail takes on hard-to-treat lymphomas

Disease control Ongoing

This early-phase trial tests whether combining the immunotherapy pembrolizumab (Keytruda) with chemotherapy drugs pralatrexate and decitabine is safe and can shrink tumors in people with relapsed peripheral or cutaneous T-cell lymphoma. About 37 adults whose cancer has returned o…

Matched conditions: PTCL

Phase: PHASE1 • Sponsor: University of Virginia • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC

PTCL

Get alerted when new PTCL trials appear

New drug cocktail takes on hard-to-treat lymphomas